EarningsQ2 2026 Earnings Report

Arrowhead Pharmaceuticals (ARWR) Q2 2026 Earnings Report

0 Followers

MX:ARWR Q2 2026 EPS Results

Actual EPS-$16.91

Consensus EPS-$19.91

Beat/MissBeat by +$3.00

One Year Ago EPS$49.99

Actual Revenue$1.34B

Expected Revenue$1.34B

Beat/MissMissed by -$1.91M

YoY Revenue Growth-86.41%

QuarterQ2 2026

Date05/07/2026

TimeAfter Close

Conference CallThursday, May 7, 2026

MX:ARWR Upcoming Earnings

Arrowhead Pharmaceuticals's next earnings date is estimated for November 30, 2026, based on past reporting schedules.

MX:ARWR Q2 2026 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 30, 2026	2026 (Q4)	-28.19 / -	-2	―
Aug 04, 2026	2026 (Q3)	-23.21 / -24.72	-22.905	-7.94% (-1.82)
May 07, 2026	2026 (Q2)	-19.91 / -16.91	49.99	-133.82% (-66.90)
Feb 05, 2026	2026 (Q1)	0.67 / 4.00	-25.268	115.83% (+29.27)
Nov 25, 2025	2025 (Q4)	-2.04 / -2.00	-24.722	91.91% (+22.72)
Aug 07, 2025	2025 (Q3)	-17.31 / -22.90	-25.086	8.70% (+2.18)
May 12, 2025	2025 (Q2)	-3.40 / 49.99	-18.542	369.61% (+68.53)
Feb 10, 2025	2025 (Q1)	-8.65 / -25.27	-22.541	-12.10% (-2.73)
Nov 26, 2024	2024 (Q4)	-20.36 / -24.72	-18.542	-33.33% (-6.18)
Aug 08, 2024	2024 (Q3)	-9.62 / -25.09	-17.451	-43.75% (-7.63)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed